Pharmacielo Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.236x

Pharmacielo Ltd cash flow conversion efficiency. Based on the latest financial reports, Pharmacielo Ltd (PCLO) has a cash flow conversion efficiency ratio of 0.236x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-3.53 Million ≈ $-2.55 Million USD) by net assets (CA$-14.94 Million ≈ $-10.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Pharmacielo Ltd (2016–2024)

Cash flow conversion efficiency of Pharmacielo Ltd from 2016 to 2024. This chart illustrates how Pharmacielo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pharmacielo Ltd stock quote for real-time trading data and today's change.

Pharmacielo Ltd Cash Flow Conversion Ratio Explained

Pharmacielo Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Pharmacielo Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmacielo Ltd ranked by their cash flow conversion efficiency. Also see PCLO market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ceres Power Holdings PLC LSE:CWR	-0.182x
WF Holding Limited Ordinary Shares NASDAQ:WFF	N/A
DGB Group NV AS:DGB	0.235x
Compagnie des Eaux de Royan PA:MLEDR	N/A
SG COMPANY S.P.A. F:7KZ	N/A
TNF Pharmaceuticals, Inc. NASDAQ:TNFA	-0.178x
Uma Exports Limited NSE:UMAEXPORTS	0.040x
Gafisa S.A SA:GFSA3	-0.084x

Annual Cash Flow Conversion Efficiency for Pharmacielo Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Pharmacielo Ltd from 2016 to 2024. Review Pharmacielo Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.52 Million ≈ $-5.44 Million	CA$-1.97 Million ≈ $-1.42 Million	0.262x	-91.45%
2023-12-31	CA$-1.68 Million ≈ $-1.22 Million	CA$-5.15 Million ≈ $-3.73 Million	3.066x	+301.87%
2022-12-31	CA$6.39 Million ≈ $4.62 Million	CA$-9.71 Million ≈ $-7.02 Million	-1.519x	-46.22%
2021-12-31	CA$19.33 Million ≈ $13.98 Million	CA$-20.07 Million ≈ $-14.52 Million	-1.039x	-20.82%
2020-12-31	CA$26.25 Million ≈ $18.99 Million	CA$-22.56 Million ≈ $-16.32 Million	-0.860x	-55.33%
2019-12-31	CA$45.47 Million ≈ $32.89 Million	CA$-25.16 Million ≈ $-18.20 Million	-0.553x	-30.88%
2018-12-31	CA$185.55K ≈ $134.23K	CA$-78.47K ≈ $-56.76K	-0.423x	+98.98%
2017-12-31	CA$91.02K ≈ $65.84K	CA$-3.79 Million ≈ $-2.74 Million	-41.637x	-12744.15%
2016-12-31	CA$9.57 Million ≈ $6.92 Million	CA$-3.10 Million ≈ $-2.24 Million	-0.324x	--

About Pharmacielo Ltd

V:PCLO Canada Drug Manufacturers - Specialty & Generic

Market Cap

$6.80 Million

CA$9.40 Million CAD

Market Cap Rank

#27864 Global

#1189 in Canada

Share Price

CA$0.05

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.14

All Time High

CA$11.02